Melphalan, 94%
Melphalan, 94%
Melphalan, 94%
Thermo Scientific Chemicals

Melphalan, 94%

Melphalan, CAS # 148-82-3, belongs to the class of nitrogen mustards with anti-neoplastic activity. | CAS: 148-82-3 | C13H18Cl2N2O2 | 305.2 g/mol
製品番号(カタログ番号)数量
4586500505 g
製品番号(カタログ番号) 458650050
価格(JPY)
-
数量:
5 g
一括またはカスタム形式をリクエストする
化学物質識別子
CAS148-82-3
IUPAC Name2-amino-3-{4-[bis(2-chloroethyl)amino]phenyl}propanoic acid
Molecular FormulaC13H18Cl2N2O2
InChI KeySGDBTWWWUNNDEQ-UHFFFAOYNA-N
SMILESNC(CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O
さらに表示
Appearance (Form)Powder
Infrared spectrumConforms
Water=<5 %
HPLC>=93 %
Appearance (Color)White to light yellow
This Thermo Scientific Chemicals brand product was originally part of the Acros Organics product portfolio. Some documentation and label information may refer to the legacy brand. The original Acros Organics product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

General Description

  • Melphalan is a phenylalanine derivative of nitrogen mustard with antineoplastic activity with the capacity to alkylate nucleic acids
  • Melphalan alkylates DNA at the N-7 position of guanine and induces DNA interstrand cross-linkages, resulting in the inhibition of DNA/RNA synthesis, inducing cytotoxicity against both dividing and non-dividing tumor cells

Applications

  • Melphalan has been used in in vitro experiments to treat multiple myeloma in cell lines and breast cancer cell lines
  • In in vivo experiments, using rats, it shows a potent therapeutic effect in cases of sarcomatous pulmonary metastases
RUO – Research Use Only

General References:

  1. Betcher, D.; Burnham, N. Melphalan. J Pediatr Oncol Nurs. 1990, 7 (1), 35-36.
  2. Nawata, S.; Abecasis, N.; Ross, H.M.; Abolhoda, A.; Cheng, H.; Sachar, K.S.; Burt, M.E. Isolated lung perfusion with melphalan for the treatment of metastatic pulmonary sarcoma. J Thorac Cardiovasc Surg. 1996, 112, (6), 1542-1547.
  3. Stühmer, T.; Arts, J.; Chatterjee, M.; Borawski,, J, Wolff A, King P, Einsele H, Leo E, Bargou RC. Preclinical anti-myeloma activity of the novel HDAC-inhibitor JNJ-26481585. Br J Haematol. 2010, 149, (4), 529-536.
  4. Bauer, G.B.; Povirk, L.F. Specificity and kinetics of interstrand and intrastrand bifunctional alkylation by nitrogen mustards at a G-G-C sequence. Nucleic Acids Res. 1997, 25, (6), 1211-1218.